Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain neuroscience education plus cyclobenzaprine for masticatory myofascial pain
RBR-9yy8w2kRecruiting
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cyclobenzaprine in temporomandibular disorder (TMD) and chronic myofascial pain (CMP) (2 arms), sponsored by Universidade Federal de Minas Gerais. Started Nov 2022; status: recruiting.
02
Drugs
cyclobenzaprine
03
Conditions
temporomandibular disorder (TMD)chronic myofascial pain (CMP)
Beyond the preview
Go deeper on RBR-9yy8w2k.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9yy8w2k.